Zambia Infant Cohort Study - Brains Optimized for Surviving and Thriving
NCT05119959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 469
Last updated 2024-11-01
Summary
Children exposed to HIV in-utero but uninfected (CHEUs) number 14.8 million globally. In Zambia, an estimated 56,000 CHEUs are born annually, a staggering fraction of the national birth cohort. Multiple studies establish that CHEUs are more neurodevelopmentally vulnerable than HIV-unexposed peers. In Zambia, there are existing effective early childhood developmental (ECD) interventions that target other vulnerable populations, but never trialed specifically for CHEUs. Scaling up ECD is now a priority of Zambia's national strategy, but CHEUs are not currently targeted.
There is a need to better understand the scope and mechanism of CHEU-related neurodevelopmental differences and what interventions are most effective. This randomized clinical trial (RCT) is a true effectiveness trial as the intervention will deploy a home-based adaptation of the same curriculum that is currently used elsewhere in the country, named Scaling Up Early Childhood Development In Zambia (SUPERCDZ). The effectiveness of a scalable early childhood development (ECD) intervention for CHEUs will be evaluated using normalized Z-scores of neurodevelopmental testing at age 24 months.
In this RCT the investigators will test the following hypotheses:
Hypothesis 1: An ECD intervention delivered by community health workers via bi-weekly home visits will improve neurodevelopmental outcomes in CHEUs.
Hypothesis 2: CHEUs have significantly worse neurodevelopmental outcomes than unexposed peers at 24 months, mediated by preterm birth, disease stage or antiretroviral (ARV) exposure.
This RCT will build on an existent, actively recruiting cohort of 1500 pregnant women-infant dyads in a peri-urban hospital in Zambia, the Zambian Infant Cohort Study (ZICS), by extending the follow-up of a subsample of infants from 6 months to 2 years amongst the last 525 children enrolled (ZICS-BOOST- Brains Optimized to Survive and Thrive). The study will have three arms: Arm 1) CHEU + ECD intervention (n=175); Arm 2) CHEU without ECD intervention (n=175); Arm 3) HUU without intervention (n=175).
Conditions
- Child Development
Interventions
- OTHER
-
ECD intervention for CHEUs
The bi-weekly community health worker-delivered ECD 1 hour intervention using the modules from the SUPERCDZ curriculum which is a Zambian adaptation of UNICEF's Nurturing Care Framework
- OTHER
-
Usual care for CHEUs
No ECD interventions will be provided by community health workers. Children will be followed at clinics for growth and monitoring, vaccinations on a MoH approved schedule.
Sponsors & Collaborators
-
Thrasher Research Fund
collaborator OTHER -
Boston University
lead OTHER
Principal Investigators
-
Julie M Herlihy, MD MPH · BU School of Public Health
-
Ethan Zulu, MBChB MSc · Right to Care - Zambia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-14
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- United States
- Zambia
Study Locations
More Related Trials
-
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
NCT00753324 ·Status: COMPLETED ·Phase: PHASE4
-
Early Infant HIV Treatment in Botswana
NCT02369406 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam)
NCT02570334 ·Status: UNKNOWN ·Phase: NA
-
Swaziland Safe Generations
NCT01891799 ·Status: COMPLETED
-
Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
NCT00067522 ·Status: UNKNOWN ·Phase: NA
-
Safe Generations Plus: Swaziland PMTCT LTF Study
NCT02969161 ·Status: COMPLETED
-
Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
NCT02249962 ·Status: COMPLETED
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
NCT02479659 ·Status: COMPLETED ·Phase: NA
-
Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project
NCT02043418 ·Status: ACTIVE_NOT_RECRUITING
-
Zambia Exclusive Breastfeeding Study
NCT00310726 ·Status: COMPLETED ·Phase: NA
-
B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV
NCT05923333 ·Status: RECRUITING ·Phase: NA
-
Chinese Network of Pediatric Antiretroviral Therapy
NCT01210924 ·Status: COMPLETED
-
Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
NCT00427297 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Improve Survival Among HIV-Exposed Infants in Botswana
NCT01229761 ·Status: COMPLETED ·Phase: PHASE2
-
Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study
NCT01116908 ·Status: COMPLETED ·Phase: NA
-
A Prospective Cohort of Children With HIV Infection
NCT00476606 ·Status: COMPLETED
-
A Study of 1592U89 in HIV-Infected Children
NCT00002197 ·Status: COMPLETED ·Phase: NA
-
Long-Term Effects of HIV Exposure and Infection in Children
NCT00006304 ·Status: COMPLETED
-
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
NCT05154513 ·Status: COMPLETED
-
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
NCT00981695 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
NCT06493357 ·Status: RECRUITING ·Phase: NA
-
A Sub-study of PREDICT Neurodevelopment Protocol
NCT02406768 ·Status: COMPLETED
-
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
NCT00000952 ·Status: COMPLETED ·Phase: PHASE1